What is Larimar Therapeutics, Inc. Common Stock's Market Cap?

Larimar Therapeutics, Inc. Common Stock's Market Cap is $409.9M, based on as-reported figures from SEC (XBRL) filings.

What is Larimar Therapeutics, Inc. Common Stock's Enterprise Value?

Larimar Therapeutics, Inc. Common Stock's Enterprise Value is $317.2M, based on as-reported figures from SEC (XBRL) filings.

What is Larimar Therapeutics, Inc. Common Stock's EV / EBITDA?

Larimar Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Larimar Therapeutics, Inc. Common Stock's Net Income (TTM)?

Larimar Therapeutics, Inc. Common Stock's Net Income (TTM) is -$172.6M, based on as-reported figures from SEC (XBRL) filings.

What is Larimar Therapeutics, Inc. Common Stock's EBITDA?

Larimar Therapeutics, Inc. Common Stock's EBITDA is -$178.7M, based on as-reported figures from SEC (XBRL) filings.

What is Larimar Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Larimar Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.66, based on as-reported figures from SEC (XBRL) filings.

What is Larimar Therapeutics, Inc. Common Stock's Net Debt?

Larimar Therapeutics, Inc. Common Stock's Net Debt is -$92.7M, based on as-reported figures from SEC (XBRL) filings.

Larimar Therapeutics, Inc. Common Stock (LRMR) Financial Statements

Larimar Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V0GD97

XNAS · usd

3.95▼ 0.13 (-3.16%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.08

Day's Range3.72 – 4.08

52-Week Range2.71 – 6.42

Volume1.0M

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees71

ExchangeXNAS

Listed2020-05-29

Share count as of August 2, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Larimar Therapeutics, Inc. Common Stock (LRMR)

What is Larimar Therapeutics, Inc. Common Stock's Market Cap?: Larimar Therapeutics, Inc. Common Stock's Market Cap is $409.9M, based on as-reported figures from SEC (XBRL) filings.
What is Larimar Therapeutics, Inc. Common Stock's Enterprise Value?: Larimar Therapeutics, Inc. Common Stock's Enterprise Value is $317.2M, based on as-reported figures from SEC (XBRL) filings.
What is Larimar Therapeutics, Inc. Common Stock's EV / EBITDA?: Larimar Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Larimar Therapeutics, Inc. Common Stock's Net Income (TTM)?: Larimar Therapeutics, Inc. Common Stock's Net Income (TTM) is -$172.6M, based on as-reported figures from SEC (XBRL) filings.
What is Larimar Therapeutics, Inc. Common Stock's EBITDA?: Larimar Therapeutics, Inc. Common Stock's EBITDA is -$178.7M, based on as-reported figures from SEC (XBRL) filings.
What is Larimar Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Larimar Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.66, based on as-reported figures from SEC (XBRL) filings.
What is Larimar Therapeutics, Inc. Common Stock's Net Debt?: Larimar Therapeutics, Inc. Common Stock's Net Debt is -$92.7M, based on as-reported figures from SEC (XBRL) filings.